Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms

Urinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known as biofilms. Urinary tract infections can be cured with antibiotics, general...

Full description

Bibliographic Details
Main Author: Telimaa, Heta
Other Authors: Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, University of Jyväskylä
Format: Master's thesis
Language:eng
Published: 2023
Subjects:
Online Access: https://jyx.jyu.fi/handle/123456789/89009
_version_ 1826225759623053312
author Telimaa, Heta
author2 Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_facet Telimaa, Heta Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä Telimaa, Heta Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_sort Telimaa, Heta
datasource_str_mv jyx
description Urinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known as biofilms. Urinary tract infections can be cured with antibiotics, generally with good success. However, increased antibiotic resistance has led to a rise of recurrent UTIs and biofilms are in fact known to reduce the effect of antibiotics. One potential alternative to treat such infections in the future is phage therapy, i.e., using viruses that kill bacteria. The aim of this study was to find out how different bacteriophages (phages) can eliminate three different UPEC strains (EC7, EC10, EC38) growing in biofilms. Five different phages were produced for each strain. Biofilms of each strain were grown in the pegs of 96-well plate lids and then further treated with two different concentrations of phage lysates. In the experiment were studied not only the potential of individual phages, but also their combined effect in pairs and in a cocktail of five phages. The results were obtained by measuring the optical density at a wavelength of 600 nm every 30 minutes for 24 hours using Tecan Spark® microplate reader. The study shows that several treatments effectively reduce bacterial growth and thus, proves the potential of phage therapy as an effective novel approach. When the results are further consider together with a parallel antibiotic study, it is clear that phage therapy is a promising alternative for the treatment of bacterial infections, especially when combined with antibiotic treatment.
first_indexed 2023-09-11T20:01:00Z
format Pro gradu
free_online_boolean 1
fullrecord [{"key": "dc.contributor.advisor", "value": "Jalasvuori, Matti", "language": "", "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.advisor", "value": "Given, Cindy", "language": "", "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.author", "value": "Telimaa, Heta", "language": "", "element": "contributor", "qualifier": "author", "schema": "dc"}, {"key": "dc.date.accessioned", "value": "2023-09-11T05:52:36Z", "language": null, "element": "date", "qualifier": "accessioned", "schema": "dc"}, {"key": "dc.date.available", "value": "2023-09-11T05:52:36Z", "language": null, "element": "date", "qualifier": "available", "schema": "dc"}, {"key": "dc.date.issued", "value": "2023", "language": "", "element": "date", "qualifier": "issued", "schema": "dc"}, {"key": "dc.identifier.uri", "value": "https://jyx.jyu.fi/handle/123456789/89009", "language": null, "element": "identifier", "qualifier": "uri", "schema": "dc"}, {"key": "dc.description.abstract", "value": "Urinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known as biofilms. Urinary tract infections can be cured with antibiotics, generally with good success. However, increased antibiotic resistance has led to a rise of recurrent UTIs and biofilms are in fact known to reduce the effect of antibiotics. One potential alternative to treat such infections in the future is phage therapy, i.e., using viruses that kill bacteria. The aim of this study was to find out how different bacteriophages (phages) can eliminate three different UPEC strains (EC7, EC10, EC38) growing in biofilms. Five different phages were produced for each strain. Biofilms of each strain were grown in the pegs of 96-well plate lids and then further treated with two different concentrations of phage lysates. In the experiment were studied not only the potential of individual phages, but also their combined effect in pairs and in a cocktail of five phages. The results were obtained by measuring the optical density at a wavelength of 600 nm every 30 minutes for 24 hours using Tecan Spark\u00ae microplate reader. The study shows that several treatments effectively reduce bacterial growth and thus, proves the potential of phage therapy as an effective novel approach. When the results are further consider together with a parallel antibiotic study, it is clear that phage therapy is a promising alternative for the treatment of bacterial infections, especially when combined with antibiotic treatment.", "language": "en", "element": "description", "qualifier": "abstract", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Submitted by Paivi Vuorio (paelvuor@jyu.fi) on 2023-09-11T05:52:36Z\nNo. of bitstreams: 0", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Made available in DSpace on 2023-09-11T05:52:36Z (GMT). No. of bitstreams: 0\n Previous issue date: 2023", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.format.extent", "value": "31", "language": "", "element": "format", "qualifier": "extent", "schema": "dc"}, {"key": "dc.language.iso", "value": "eng", "language": null, "element": "language", "qualifier": "iso", "schema": "dc"}, {"key": "dc.rights", "value": "In Copyright", "language": null, "element": "rights", "qualifier": null, "schema": "dc"}, {"key": "dc.title", "value": "Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms", "language": "", "element": "title", "qualifier": null, "schema": "dc"}, {"key": "dc.type", "value": "master thesis", "language": null, "element": "type", "qualifier": null, "schema": "dc"}, {"key": "dc.identifier.urn", "value": "URN:NBN:fi:jyu-202309115037", "language": "", "element": "identifier", "qualifier": "urn", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Master\u2019s thesis", "language": "en", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Pro gradu -tutkielma", "language": "fi", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Matemaattis-luonnontieteellinen tiedekunta", "language": "fi", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Faculty of Sciences", "language": "en", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Bio- ja ymp\u00e4rist\u00f6tieteiden laitos", "language": "fi", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Department of Biological and Environmental Science", "language": "en", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "Jyv\u00e4skyl\u00e4n yliopisto", "language": "fi", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "University of Jyv\u00e4skyl\u00e4", "language": "en", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Solu- ja molekyylibiologia", "language": "fi", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Cell and molecular biology", "language": "en", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "yvv.contractresearch.funding", "value": "0", "language": "", "element": "contractresearch", "qualifier": "funding", "schema": "yvv"}, {"key": "dc.type.coar", "value": "http://purl.org/coar/resource_type/c_bdcc", "language": null, "element": "type", "qualifier": "coar", "schema": "dc"}, {"key": "dc.rights.copyright", "value": "\u00a9 The Author(s)", "language": null, "element": "rights", "qualifier": "copyright", "schema": "dc"}, {"key": "dc.rights.accesslevel", "value": "openAccess", "language": null, "element": "rights", "qualifier": "accesslevel", "schema": "dc"}, {"key": "dc.type.publication", "value": "masterThesis", "language": null, "element": "type", "qualifier": "publication", "schema": "dc"}, {"key": "dc.subject.oppiainekoodi", "value": "4013", "language": "", "element": "subject", "qualifier": "oppiainekoodi", "schema": "dc"}, {"key": "dc.subject.yso", "value": "bakteriofagit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "fagiterapia", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "antibioottiresistenssi", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "virtsatieinfektio", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "mikrobiologia", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "kolibakteerit", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "bacteriophages", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "phage therapy", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "antibiotic resistance", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "urinary tract infection", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "microbiology", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "Escherichia coli", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.rights.url", "value": "https://rightsstatements.org/page/InC/1.0/", "language": null, "element": "rights", "qualifier": "url", "schema": "dc"}]
id jyx.123456789_89009
language eng
last_indexed 2025-02-18T10:54:49Z
main_date 2023-01-01T00:00:00Z
main_date_str 2023
online_boolean 1
online_urls_str_mv {"url":"https:\/\/jyx.jyu.fi\/bitstreams\/8a7afd4d-2659-4121-b244-860f549992f2\/download","text":"URN:NBN:fi:jyu-202309115037.pdf","source":"jyx","mediaType":"application\/pdf"}
publishDate 2023
record_format qdc
source_str_mv jyx
spellingShingle Telimaa, Heta Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms Solu- ja molekyylibiologia Cell and molecular biology 4013 bakteriofagit fagiterapia antibioottiresistenssi virtsatieinfektio mikrobiologia kolibakteerit bacteriophages phage therapy antibiotic resistance urinary tract infection microbiology Escherichia coli
title Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
title_full Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
title_fullStr Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
title_full_unstemmed Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
title_short Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
title_sort potential of phage therapy against uropathogenic antibiotic resistant escherichia coli biofilms
title_txtP Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
topic Solu- ja molekyylibiologia Cell and molecular biology 4013 bakteriofagit fagiterapia antibioottiresistenssi virtsatieinfektio mikrobiologia kolibakteerit bacteriophages phage therapy antibiotic resistance urinary tract infection microbiology Escherichia coli
topic_facet 4013 Cell and molecular biology Escherichia coli Solu- ja molekyylibiologia antibioottiresistenssi antibiotic resistance bacteriophages bakteriofagit fagiterapia kolibakteerit microbiology mikrobiologia phage therapy urinary tract infection virtsatieinfektio
url https://jyx.jyu.fi/handle/123456789/89009 http://www.urn.fi/URN:NBN:fi:jyu-202309115037
work_keys_str_mv AT telimaaheta potentialofphagetherapyagainsturopathogenicantibioticresistantescherichiacolibiofilm